What do IBM, Continental and Olympus all have in Common? They've all taken steps to maximize the value of their patents, they've reduced the risk of PAE litigation and they joined the LOT Network in 2020.

Richardson Oliver Law Group, Cipher, and LOT Network have just launched a report that discusses the 2.7 million assets under the LOT protection umbrella that companies like IBM and Continental have opted into.

Marketing and selling patents in the current environment - hear from the experts

10,000+ patents, spending $10M’s per year, cross-licenses, and license potential with dozens of companies, what’s the value of the portfolio to the business? Is your patent strategy valuable to your company? How? OK, tag you are it, what is the answer? The problem seems intractable.

Join Gene Quinn, patent attorney and founder of IPWatchdog.com and Erik Reeves, Founder of AcclaimIP and CTO of Anaqua, and Kent Richardson for a free webinar discussion on building a portfolio versus buying patents, identifying gaps in your patent coverage, and unlocking the secrets of your own patent portfolio to identify needs.

Why is patent value a better metric to use to set patent strategy? What sources of patent value can be identified for high technology companies? We review how patents are used and how they can be valued based upon their use.

The profiles of patent buyers, as well as their motivations, are changing. This makes the ability to package assets to maximize deal-making success more important than ever.

The sales market for patent rights continues to vex analysts – especially in terms of valuation. In their Patently-O Patent Law Journal article, Professor Mark Lemley teams up with the Richardson Oliver Law Group to provide further guidance.

What causes operating companies to sell their patents? Our intuition tells us that patent sales take place when the seller is in financial distress or the company is underperforming. We wanted to test whether the data aligned with our intuition.

Targeting the revenues of other companies according to the patent assertion risk they present effectively defines your patent development and external acquisition strategies. We show how to build a financial model to determine where you spend your patent development and buying dollars and then how to calculate risk and ROI.